Longeveron reports topline results from ELPIS II Phase 2b
Headline indicates topline results from ELPIS II Phase 2b evaluating laromestrocel for hypoplastic left heart syndrome (HLHS).
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.